Akari Therapeutics PLC (AKTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -45.305 | -69.942 | -73.633 | -146.921 | -162.03 | -132.739 | -122.091 | -112.345 |
Return on Equity (%) | -49.404 | -80.468 | -90.031 | -251.733 | -363.756 | -233.269 | -315.194 | -393.127 |
Return on Invested Capital (%) | -51.315 | -80.292 | -103.518 | -250.807 | -371.529 | -230.819 | -409.509 | -577.602 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.035 | 0.02 | 0.008 | N/A | 0.004 | 0.001 | 0.001 | N/A |
Earnings Per Share | -0.022 | -0.019 | -0.013 | -0.011 | -0.008 | -0.004 | -0.002 | -0.001 |
Cash Per Share | 0.029 | 0.019 | 0.004 | 0.004 | 0.006 | 0.002 | 0.002 | N/A |
Working Capital Per Share | 0.035 | 0.02 | 0.008 | N/A | 0.004 | 0.001 | 0.001 | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.022 | -0.025 | -0.015 | -0.011 | -0.008 | -0.004 | -0.003 | -0.001 |
EBITDA Per Share | -0.022 | -0.025 | -0.015 | -0.011 | -0.008 | -0.004 | -0.003 | -0.001 |
Free Cash Flow Per Share | -0.022 | -0.019 | -0.013 | -0.011 | -0.008 | -0.004 | -0.002 | -0.001 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,18B | 1,53B | 1,58B | 1,58B | 2,25B | 4,76B | 7,44B | 13,23B |
Fin d'année 31 Décembre 2023 | Sept 2020 | Déc 2020 | Mar 2021 | Juin 2021 | Sept 2021 | Déc 2021 | Mar 2022 | Juin 2022 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | 2,25B | N/A | N/A | N/A | 4,76B | N/A | 5,93B |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 24,76M |
Ratio cours/bénéfice | -1,98 |
Ratio prix/ventes | 73,68 |
Ratio prix/liquidités | 6,31 |
Ratio prix/valeur comptable | 24,56 |
Rendement de dividende | - |
Actions en circulation | 24,76M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales